Keywords: aventis, licenses, ketek, sankyo, fujisawa, franco-german, drugmaker

Aventis licenses Ketek to Sankyo, Fujisawa

Article | 17 February 2003

Franco-German drugmaker Aventis has licensed Japanese rights to itsnew antibiotic Ketek (telithromycin) to Sankyo and Fujisawa Pharmaceutical. The drug has ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in